Advair HFA 230-21 MCG inhaler 12GM
Ended Awarded Last action
- Contract number
- SPE2DR26F6RD1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,724
Award facts
- Contract value 100% obligated
- $10,724.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,724.01 to AmerisourceBergen Drug Corp for Advair HFA 230-21 MCG inhaler 12GM pharmaceutical products on November 25, 2025, with an ultimate completion date of November 26, 2025. This firm fixed-price delivery order is non-set-aside and represents a competitive award to the prime contractor, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company's IDC with DLA Troop Support Medical enables supply of a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to support military healthcare programs globally. This delivery order for Advair HFA inhalers demonstrates the company's ongoing role in supplying respiratory medications and other essential pharmaceutical products to federal health systems.
Quick answers
Who was awarded contract SPE2DR26F6RD1?
SPE2DR26F6RD1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F6RD1 worth?
The government has obligated $10,724 on SPE2DR26F6RD1.
Is contract SPE2DR26F6RD1 an order under another contract?
Yes. SPE2DR26F6RD1 is a delivery order under SPE2DR25D2108, an indefinite delivery contract.
Was contract SPE2DR26F6RD1 competed?
The extent of competition for SPE2DR26F6RD1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award